According to GlobalData’s medical device pipeline database, 1439 Instruments devices are in various stages of development globally. GlobalData’s report Instruments provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, 738 are in active development, while the remaining 713 are in an inactive stage of development. There are 475 products in the early stages of development, and the remaining 263 are in the late stages of development.
In Vitro Diagnostics (IVD) include reagents, instruments and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. An IVD instrument, or in vitro diagnostic instrument, is a device that is used to perform in vitro diagnostic tests. IVD instruments are used to detect diseases, monitor patient health, and guide treatment decisions.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Instruments pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Instruments devices. Overall, most of these Instruments pipeline devices are being developed by private entities.
Key players involved in the active development of Instruments include Johns Hopkins University, University of Pennsylvania, Stanford University, Stanford University, Curetis, University of California Berkeley, University of Toronto, University of California Irvine, University of California Los Angeles and Baebies.
For a complete picture of the developmental pipeline for Instruments devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
